Skip to content
lifestyle.getpetsavvy.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Keros Therapeutics, Inc.
Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD
September 28, 2026
Keros Therapeutics Announces $5 Million Share Repurchase Authorization
September 8, 2026
Keros Therapeutics Reports Second Quarter 2026 Financial Results
August 3, 2026
Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
July 30, 2026
Keros Therapeutics Appoints Anne Prener to its Board of Directors
June 25, 2026
Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
May 14, 2026
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
March 5, 2026